Regulatory News

UPDATE 1-Dynavax stops development of allergy drug, shares fall 8:19am EDT

May 16 (Reuters) - Dynavax Technologies Corp said it would stop developing its experimental ragweed allergy drug, Tolamba, after it failed to meet the main goal of a mid-stage clinical trial, sending its shares down more than 7 percent.  Full Article

 
Western majors escape new Kazakh oil export duty 6:29am EDT 

ALMATY, May 16 (Reuters) - The government of Kazakhstan unveiled on Friday a preliminary list of companies subject to a new oil export duty which, as expected, does not include any Western majors.  Full Article 

Photo

Cox Enterprises is buying online advertising firm Adify for at least $300 million -- not a bad multiple on expected 2008 revenues of $35 million.  Go to Blog 

 
Don't miss another deal. Get our daily newsletter. Sign up now
Photo
Execs defend humans in high-tech markets Friday, 9 May 2008 08:04pm EDT

NEW YORK (Reuters) - The heads of the world's biggest stock exchanges agree there is still room for the "human element" in a high-speed trading environment that has aggressively gone electronic.  Full Article 

Global Equity Offerings